| pubmed-article:15669765 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15669765 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:15669765 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:15669765 | lifeskim:mentions | umls-concept:C0700287 | lld:lifeskim |
| pubmed-article:15669765 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:15669765 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:15669765 | lifeskim:mentions | umls-concept:C0441994 | lld:lifeskim |
| pubmed-article:15669765 | lifeskim:mentions | umls-concept:C0070785 | lld:lifeskim |
| pubmed-article:15669765 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:15669765 | pubmed:dateCreated | 2005-1-26 | lld:pubmed |
| pubmed-article:15669765 | pubmed:abstractText | The quantification of PC hydroperoxide (PCOOH) in human plasma was studied by HPLC with chemiluminescence detection (HPLC-CL). We identified for the first time the monohydroperoxide of 1-palmitoyl-2-linoleoyl-PC hydroperoxide (PC 16:0/18:2-OOH) in plasma by LC-MS and HPLC-CL. The standard compound, PC 16:0/18:2-OOH (synthetic PCOOH), as well as PCOOH from egg yolk, was used. Comparison of the PCOOH concentration in each participant's plasma as determined by use of a Finepak SIL NH2 column with 2-propanol/methanol/water as the mobile phase (system A, the conventional method) gave a higher concentration than did an LC-18-DB column with methanol containing 0.01% triethylamine (system B). The mean PCOOH concentration for the 43 healthy volunteers was 55.1+/-30.4 pmol/mL (mean+/-SD) for system A and 16.3+/-9.9 pmol/mL for system B. Moreover, the main peak of the plasma extract appeared at a different time from that of synthetic PCOOH or egg yolk PCOOH in system A, whereas in system B plasma sample retention time practically corresponded to that of standard PCOOH. These findings confirm that the PCOOH plasma concentration is not so high as previously reported. | lld:pubmed |
| pubmed-article:15669765 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15669765 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15669765 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15669765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15669765 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15669765 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15669765 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15669765 | pubmed:issn | 0024-4201 | lld:pubmed |
| pubmed-article:15669765 | pubmed:author | pubmed-author:NaitoTakeakiT | lld:pubmed |
| pubmed-article:15669765 | pubmed:author | pubmed-author:UenoYasuhiroY | lld:pubmed |
| pubmed-article:15669765 | pubmed:author | pubmed-author:AdachiJunkoJ | lld:pubmed |
| pubmed-article:15669765 | pubmed:author | pubmed-author:NagasakiYasus... | lld:pubmed |
| pubmed-article:15669765 | pubmed:author | pubmed-author:YoshiokaNaoki... | lld:pubmed |
| pubmed-article:15669765 | pubmed:author | pubmed-author:FunaeRikaR | lld:pubmed |
| pubmed-article:15669765 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15669765 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:15669765 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15669765 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15669765 | pubmed:pagination | 891-6 | lld:pubmed |
| pubmed-article:15669765 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:meshHeading | pubmed-meshheading:15669765... | lld:pubmed |
| pubmed-article:15669765 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15669765 | pubmed:articleTitle | Phosphatidylcholine hydroperoxide levels in human plasma are lower than previously reported. | lld:pubmed |
| pubmed-article:15669765 | pubmed:affiliation | Department of Legal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. adachi@med.kobe-u.ac.jp | lld:pubmed |
| pubmed-article:15669765 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15669765 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15669765 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
